Related Experiment Videos

[Previous infection with Chlamydia pneumoniae and long-term prognosis in patients with acute coronary syndrome with

Alessandro Sionis1, Xavier Bosch, José L Marín

  • 1Institut de Malalties Cardiovasculars, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Departamento de Medicina, Universidad de Barcelona, Barcelona, España.

Medicina Clinica
|May 19, 2005
PubMed

Insights

Prior Chlamydia pneumoniae infection does not increase cardiovascular event risk in acute coronary syndrome patients. This study found no association between C. pneumoniae seropositivity and major cardiac events in non-ST segment elevation acute coronary syndromes.

Area of Science:

  • Infectious Disease Epidemiology
  • Cardiovascular Medicine
  • Microbiology

Context:

  • Conflicting data exists regarding Chlamydia pneumoniae (C. pneumoniae) exposure and cardiovascular events.
  • Previous studies in stable coronary artery disease yielded contradictory results.
  • The prognostic value of C. pneumoniae seropositivity in acute coronary syndromes (ACS) remains unclear.

Purpose:

  • To prospectively investigate the association between C. pneumoniae seropositivity and cardiovascular events in patients with non-ST segment elevation acute coronary syndromes (NSTE-ACS).

Summary:

  • A prospective cohort study included 259 patients with NSTE-ACS, measuring serum IgG antibodies against C. pneumoniae.
  • Over a mean follow-up of 28 months, no significant difference in cardiovascular death or myocardial infarction was observed between seropositive and seronegative patients across various IgG titers.
  • Adjusted relative risks for major cardiac events were consistently around 1.0, indicating no increased risk associated with C. pneumoniae seropositivity.

Impact:

  • This research indicates that C. pneumoniae IgG seropositivity is not a predictor of adverse cardiovascular outcomes in patients presenting with NSTE-ACS.
  • Findings contribute to understanding the role of infectious agents in cardiovascular disease pathogenesis.
  • Results may inform clinical risk stratification and management strategies for ACS patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...